1. Home
  2. BMBL vs BCAX Comparison

BMBL vs BCAX Comparison

Compare BMBL & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMBL
  • BCAX
  • Stock Information
  • Founded
  • BMBL 2014
  • BCAX 2018
  • Country
  • BMBL United States
  • BCAX United States
  • Employees
  • BMBL N/A
  • BCAX N/A
  • Industry
  • BMBL Computer Software: Prepackaged Software
  • BCAX
  • Sector
  • BMBL Technology
  • BCAX
  • Exchange
  • BMBL Nasdaq
  • BCAX NYSE
  • Market Cap
  • BMBL 828.7M
  • BCAX 670.9M
  • IPO Year
  • BMBL 2021
  • BCAX 2024
  • Fundamental
  • Price
  • BMBL $4.34
  • BCAX $13.03
  • Analyst Decision
  • BMBL Hold
  • BCAX Strong Buy
  • Analyst Count
  • BMBL 17
  • BCAX 6
  • Target Price
  • BMBL $7.56
  • BCAX $34.20
  • AVG Volume (30 Days)
  • BMBL 3.6M
  • BCAX 603.5K
  • Earning Date
  • BMBL 05-07-2025
  • BCAX 03-27-2025
  • Dividend Yield
  • BMBL N/A
  • BCAX N/A
  • EPS Growth
  • BMBL N/A
  • BCAX N/A
  • EPS
  • BMBL N/A
  • BCAX N/A
  • Revenue
  • BMBL $1,071,643,000.00
  • BCAX N/A
  • Revenue This Year
  • BMBL N/A
  • BCAX N/A
  • Revenue Next Year
  • BMBL $0.20
  • BCAX N/A
  • P/E Ratio
  • BMBL N/A
  • BCAX N/A
  • Revenue Growth
  • BMBL 1.88
  • BCAX N/A
  • 52 Week Low
  • BMBL $4.19
  • BCAX $11.10
  • 52 Week High
  • BMBL $12.49
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • BMBL 32.28
  • BCAX N/A
  • Support Level
  • BMBL $4.46
  • BCAX N/A
  • Resistance Level
  • BMBL $4.88
  • BCAX N/A
  • Average True Range (ATR)
  • BMBL 0.22
  • BCAX 0.00
  • MACD
  • BMBL 0.06
  • BCAX 0.00
  • Stochastic Oscillator
  • BMBL 17.24
  • BCAX 0.00

About BMBL Bumble Inc.

Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: